Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-79
SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Eligibility criteria

Qualifiers

Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty

Disqualifiers

Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.

Trial design

Treatments tested in this trial

  • oral tranexamic acid
  • Placebo

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

1
University of Alabama at Birmingham35205, BirminghamAlabama, United States

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor